Zhaoke Ophthalmology (06622) reported that its authorized share capital remained at 1,600,000,000,000 ordinary shares, with a par value of USD0.00000025 each, for a total of USD400,000.
The total number of issued shares increased from 547,955,012 to 547,970,012, reflecting an additional 15,000 shares issued during November 2025. According to the disclosed data, all newly issued shares resulted from the exercise of share options under a Post-IPO share option scheme.
The company recorded HKD48,900 in total funds raised from these share option exercises. There were no movements in treasury shares during the period under review.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.